KEEP UP WITH THE LATEST IN INDUSTRY NEWS!
From news about new medicines, pharmacy business insights, and the pharmaceutical industry in general—this is your source!
DrugTopics articles
- Small Doses: May 13 to May 17 May 18, 2024Check out a recap of important pharmacy news you might have missed this week, dispensed in small doses.
- National Women's Health Week: Contraceptive Counseling, OTC Products, and More May 18, 2024As Women’s Health Week comes to a close, check out some of our recent women’s health coverage. Dive deep into everything from skin care myths to reproductive care access.
- FDA Roundup: Updated Label for Altuviiio, CRL Given to Heplisav-B May 17, 2024Check out important updates from the FDA for the week of May 13.
- Q&A: Pharmacist Turned Coffee Shop Owner on the Current State of Independent Pharmacy May 17, 2024Chris Schaffner, owner of Schaffner Pharmacy and Apothecary Coffee in Sedro Woolley, Washington, discussed the state of today’s independent pharmacy market, as well as his own pharmacy operations.
- New Evaluation Standards Needed to Sustain Diabetes Technology Innovation May 17, 2024Since diabetes technology innovation, combined with strong patient demand, has outpaced current evaluation methods, investigators are calling for new approaches that “keep up with the times.”
- Slideshow: The 5 Types of Asthma and Their Common Triggers May 17, 2024While many people may be unaware of the different types of asthma, there are 5 ways individuals can experience the condition, with common triggers that heighten symptoms.
- FDA Approves Tarlatamab-dlle for Extensive-Stage Small Cell Lung Cancer May 17, 2024Amgen’s Tarlatamab-dlle (Imdelltra) is the first and only approved DLL3-targeting bispecific T-cell engager therapy for the aggressive form of lung cancer.
- Rx Roundup: Quiz of the Week — May 17, 2024 May 17, 2024Test your pharmacy news knowledge with our weekly quiz.
- Check Your Work: Understanding Food Allergies May 17, 2024Dive in and learn more about the answers to yesterday’s quiz.
- Government Dedicates Nearly $200 Million to Contain US Bird Flu Outbreak May 16, 2024Over half of the money is set to assist the overall effort to stop the virus, while the remaining funds will go to dairy farms affected by the bird flu outbreak.
Pharmacy Times articles
- Rotaxane Actuators Study Unveils Promising Advancements for Drug Delivery Systems May 18, 2024Researchers from the University of Manchester have developed a technique using rotaxane actuators in force-controlled release systems, enabling precise and efficient release of multiple molecules simultaneously.
- Obesity and Metabolic Syndrome Factors Potentially Associated With Breast Cancer Receptor Subtypes, Mortality May 17, 2024Both MetS and obesity status have independent and differential associations with breast cancer, and may serve as separate targets for breast cancer prediction and prevention strategies.
- The Positive Impact of Pharmacist Led Research at Mayo Clinic: Enhancing Patient Care and Treatment Opportunities May 17, 2024Jodi Taraba offers valuable insights on the benefits of involving oncology pharmacists in clinical trial research to advance treatment and care for patients with cancer.
- SDOH Framework Highlights Role of Health System Specialty Pharmacists May 17, 2024Future potential directions include measuring the impact of clinical pharmacist interventions on referral utility, disease-specific clinical outcomes, patient satisfaction, medication adherence, and absenteeism.
- This Skin Cancer Awareness Month, Remind Patients of the Prevention Basics May 17, 2024As summer approaches, remind patients to go back to basics with sunscreen and self-examinations.
- The FDA Grants Accelerated Approval to Tarlatamab-dlle in Small Cell Lung Cancer May 17, 2024Tarlatamab is a first-in-class immunotherapy that binds to DLL3 tumor cells and CD3 T-cells, to kill DLL3-expressing SCLC.
- Condition Watch: May 2024 May 17, 2024
- Products: May 2024 May 17, 2024
- Pharmacy Influencers Share How to Balance Passions and Career May 17, 2024Three influencers from around the world showcase the passions they pursue outside the pharmacy industry.
- Expert Discusses Unique Challenges of Distributing Specialty Drugs May 17, 2024Natalie Bedford, senior vice president, US Pharmaceutical Distribution Services at McKesson, discusses the unique challenges of distributing specialty drugs.
Helping You Navigate the Returns Process!
Pedigree Statement
Flash Returns, LLC has strict standard operating procedures and a pharmaceutical services agreement (PSA) with it’s clients…
Flash Returns, LLC has strict standard operating procedures and a pharmaceutical services agreement (PSA) with its clients. This is to ensure that the reverse distribution portion of the supply chain that we service keeps its functionality and integrity for our customers and the public.
Several pedigree and distribution level issues have been raised in the industry. Discounted, indigent-pricing, short dated, bulk purchase, secondary distribution, or DSCSA non-compliant sales could affect the credit available for a product based on a manufacturers determination. We ask that you do not return these products for credit as they are not eligible in most cases. Flash Returns LLC may choose to dispose of these on the pharmacies behalf at no charge if the cost is low relative to the return. Most customers purchasing products from reputable wholesalers will not encounter these issues, however all pharmacies are asked to acknowledge our policy on pedigree and legitimacy of product here and by signing the PSA before a return is initiated.
Some manufacturers may require proof the price paid for a product and what wholesaler distributed the product. Issues causing triggering this could be: bulk or large quantities of single items or lots, or products purchased speculatively. In some cases we may request invoices from the customer to ensure Flash Returns or manufacturer policy is being met. If none are available or if the information isn’t accepted by the manufacturer it could cause the return to be non-returnable.
Flash Returns, LLC cannot guarantee or be liable for the value or credit for products that were purchased outside of manufacturer accepted distribution channels. This could include products: purchased from a wholesaler that is not an approved vendor, products not purchased directly from a particular manufacturer, purchased on a speculative basis, diverted or counterfeit products, foreign products, and any product purchased on a non-returnable basis, including short-dated product purchased at discounted pricing.
At any time, Flash Returns, LLC or a manufacturer may require invoices or pedigree information demonstrating proof of purchase. If product has been shipped by Flash Returns, LLC or the Customer to a manufacturer or their agent, Flash Returns, LLC cannot guarantee or facilitate the return of product to the Customer. Manufacturers reverse the right to destroy product they deem not credit worthy or suspect. Manufacturers agreeing to return product to customers will do so at the customers expense. Flash Returns, LLC shall not be responsible for reimbursing a Customer for such product.
If Customer is unable to have product returned within 21 days, product is subject to be destroyed without any payment or credit issued to Customer. In any dispute, failure by Customer to provide invoices for a product or pedigree if requested shall release Flash Returns, LLC from any and all liability of products involved in dispute including the full value of the product. More information on drug pedigrees is available on the FDA website at:
Pedigree Statement
P: 833.553.5274
E: SignUp@FlashReturns.com